Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CareDx (CDNA)
NASDAQ:CDNA
Holding CDNA?
Track your performance easily
CDNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.80 - $34.84
Previous Close$29.26
Volume184.48K
Average Volume (3M)931.18K
Market Cap
$1.60B
Enterprise Value$1.34B
Total Cash (Recent Filing)$228.87M
Total Debt (Recent Filing)$25.39M
Price to Earnings (P/E)―
Beta1.83
Next Earnings
Oct 31, 2024EPS Estimate
-$0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.99
Shares Outstanding52,740,008
10 Day Avg. Volume660,797
30 Day Avg. Volume931,179
Standard Deviation0.23
R-Squared0.16
Alpha0.00745
Financial Highlights & Ratios
Price to Book (P/B)5.83
Price to Sales (P/S)5.35
Price to Cash Flow (P/CF)21.00
P/FCF Ratio23.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.51
Enterprise Value/Gross Profit7.51
Enterprise Value/Ebitda-26.96
Forecast
1Y Price Target
$34.00Price Target Upside12.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
CareDx News
PremiumCompany Announcements
CareDx Announces Key Executive Appointments and Investor Day
Bulls Say, Bears Say
Bulls Say
Financial PerformanceShares of CDNA are up +20% following a strong Q2 revenue and EBITDA beat-and-raise.
Leadership ChangesThe company made a few changes to its leadership team, including the hire of diagnostics industry veteran Keith Kennedy as COO.
Regulatory DevelopmentsCMS' reversal of its draft LCD removed a big overhang for Tx ctrs & investors.
Bears Say
Analyst RecommendationWith many positives played out & growth deceleration, analyst recommends taking profits.
GrowthExpect growth to decelerate from high-teens, to ~+5%.
RevenueThe proposed rule had the effect of reducing annual revenue by as much as $70-$90 million.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CDNA FAQ
What was CareDx’s price range in the past 12 months?
CareDx lowest stock price was $4.80 and its highest was $34.84 in the past 12 months.
What is CareDx’s market cap?
Currently, no data Available
When is CareDx’s upcoming earnings report date?
CareDx’s upcoming earnings report date is Oct 31, 2024 which is in 41 days.
How were CareDx’s earnings last quarter?
CareDx released its earnings results on Jul 31, 2024. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.399 by $0.369.
Is CareDx overvalued?
According to Wall Street analysts CareDx’s price is currently Undervalued.
Does CareDx pay dividends?
CareDx does not currently pay dividends.
What is CareDx’s EPS estimate?
CareDx’s EPS estimate is -$0.26.
How many shares outstanding does CareDx have?
CareDx has 52,740,010 shares outstanding.
What happened to CareDx’s price movement after its last earnings report?
CareDx reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.399. Following the earnings report the stock price went up 17.959%.
Which hedge fund is a major shareholder of CareDx?
Among the largest hedge funds holding CareDx’s share is ARK Investment Management LLC. It holds CareDx’s shares valued at 89M.
---
CareDx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$34.00 (12.17% Upside)
$34.00 (12.17% Upside)
Blogger Sentiment
Neutral
CDNA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 253.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
269.91%
12-Months-Change
Fundamentals
Return on Equity
-47.66%
Trailing 12-Months
Asset Growth
-9.33%
Trailing 12-Months
Company Description
CareDx
CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
---
CDNA Earnings Call
Q2 2024
0:00 / 0:00
---
CDNA Stock 12 Month Forecast
Average Price Target
$34.00
▲(12.17% Upside)
Technical Analysis
Best Analysts Covering CDNA
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+2.99%
reiterated a buy rating 2 months ago
Copying Matthew Sykes's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +2.99% per trade.
---